Biotech Target N V - Net Worth and Insider Trading
Biotech Target N V Net Worth
The estimated net worth of Biotech Target N V is at least $329 Million dollars as of 2024-12-27. Biotech Target N V is the 10% Owner of Radius Health Inc and owns about 8,733,538 shares of Radius Health Inc (RDUS) stock worth over $284 Million. Biotech Target N V is the 10% Owner of Macrogenics Inc and owns about 9,929,963 shares of Macrogenics Inc (MGNX) stock worth over $32 Million. Biotech Target N V is also the 10% Owner of Esperion Therapeutics Inc and owns about 4,477,964 shares of Esperion Therapeutics Inc (ESPR) stock worth over $10 Million. Besides these, Biotech Target N V also holds Cidara Therapeutics Inc (CDTX) , Molecular Templates Inc (MTEM) . Details can be seen in Biotech Target N V's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Biotech Target N V has not made any transactions after 2024-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Biotech Target N V
Biotech Target N V Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotech Target N V owns 5 companies in total, including Radius Health Inc (RDUS) , Esperion Therapeutics Inc (ESPR) , and Cidara Therapeutics Inc (CDTX) among others .
Click here to see the complete history of Biotech Target N V’s form 4 insider trades.
Insider Ownership Summary of Biotech Target N V
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RDUS | Radius Health Inc | 2022-05-18 | 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2021-05-24 | 10 percent owner |
| CDTX | Cidara Therapeutics Inc | 2017-11-15 | 10 percent owner |
 | | 2023-10-02 | 10 percent owner |
| | 2024-11-14 | 10 percent owner |
Biotech Target N V Latest Holdings Summary
Biotech Target N V currently owns a total of 5 stocks. Among these stocks, Biotech Target N V owns 8,733,538 shares of Radius Health Inc (RDUS) as of May 18, 2022, with a value of $284 Million and a weighting of 86.19%. Biotech Target N V owns 9,929,963 shares of Macrogenics Inc (MGNX) as of October 2, 2023, with a value of $32 Million and a weighting of 9.84%. Biotech Target N V also owns 4,477,964 shares of Esperion Therapeutics Inc (ESPR) as of May 24, 2021, with a value of $10 Million and a weighting of 3.16%. The other 2 stocks Cidara Therapeutics Inc (CDTX) , Molecular Templates Inc (MTEM) have a combined weighting of 0.81% among all his current holdings.
Latest Holdings of Biotech Target N V
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RDUS | Radius Health Inc | 2022-05-18 | 8,733,538 | 32.47 | 283,577,979 |
| MGNX | Macrogenics Inc | 2023-10-02 | 9,929,963 | 3.26 | 32,371,679 |
| ESPR | Esperion Therapeutics Inc | 2021-05-24 | 4,477,964 | 2.32 | 10,388,876 |
| CDTX | Cidara Therapeutics Inc | 2017-11-15 | 114,764 | 23.22 | 2,664,820 |
| MTEM | Molecular Templates Inc | 2024-11-14 | 0 | 0.05 | 0 |
Holding Weightings of Biotech Target N V
Biotech Target N V Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotech Target N V has made a total of 9 transactions in Radius Health Inc (RDUS) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Radius Health Inc is the acquisition of 477,824 shares on May 18, 2022, which cost Biotech Target N V around $3 Million.
According to the SEC Form 4 filings, Biotech Target N V has made a total of 12 transactions in Macrogenics Inc (MGNX) over the past 5 years, including 12 buys and 0 sells. The most-recent trade in Macrogenics Inc is the acquisition of 150,000 shares on October 2, 2023, which cost Biotech Target N V around $669,000.
According to the SEC Form 4 filings, Biotech Target N V has made a total of 4 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 100,000 shares on May 24, 2021, which cost Biotech Target N V around $2 Million.
More details on Biotech Target N V's insider transactions can be found in the Insider Trading History of Biotech Target N V table.Insider Trading History of Biotech Target N V
- 1
Biotech Target N V Trading Performance
GuruFocus tracks the stock performance after each of Biotech Target N V's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biotech Target N V is 5.47%. GuruFocus also compares Biotech Target N V's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biotech Target N V within 3 months outperforms 27 times out of 61 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Biotech Target N V's insider trading performs compared to the benchmark.
Performance of Biotech Target N V
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.34 | | | | | |
| Relative Return to S&P 500(%) | 5.21 | | | | | |
Biotech Target N V Ownership Network
Biotech Target N V Owned Company Details
What does Radius Health Inc do?
Who are the key executives at Radius Health Inc?
Biotech Target N V is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Chief Business Officer Chhaya Shah , and Vice President & Sales Danielle Holtschlag .
Radius Health Inc (RDUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Radius Health Inc Insider Transactions
Biotech Target N V Mailing Address
Above is the net worth, insider trading, and ownership report for Biotech Target N V. You might contact Biotech Target N V via mailing address: Ara Hill Top Building, Unit A-5, Pletterijweg Oost 1, Curacao, Willemstad P8 000000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
